Compare PLSE & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLSE | TRIN |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | 106 |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2015 | N/A |
| Metric | PLSE | TRIN |
|---|---|---|
| Price | $19.08 | $17.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $22.00 | $16.00 |
| AVG Volume (30 Days) | 210.1K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $840.00 | $30.41 |
| Revenue Next Year | $287.54 | $10.00 |
| P/E Ratio | ★ N/A | $7.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $13.76 |
| 52 Week High | $26.30 | $17.38 |
| Indicator | PLSE | TRIN |
|---|---|---|
| Relative Strength Index (RSI) | 41.66 | 68.59 |
| Support Level | $17.32 | $14.31 |
| Resistance Level | $20.40 | $17.20 |
| Average True Range (ATR) | 1.37 | 0.35 |
| MACD | -0.40 | 0.08 |
| Stochastic Oscillator | 12.11 | 78.92 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Trinity Capital Inc is an internally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, capital appreciation through investments across five distinct vertical markets. The company is focused on achieving its investment objective by operating as a specialty lending company that provides debt, including loans, equipment financings, and asset-based lending, to growth-oriented companies, including institutional investor-backed companies. Its investment portfolio mainly comprises private companies that have begun to have success selling their products to the market and need additional capital to expand their operations and sales.